SynBa: improved estimation of drug combination synergies with uncertainty quantification

Author:

Zhang Haoting12,Ek Carl Henrik1,Rattray Magnus34ORCID,Milo Marta5

Affiliation:

1. Department of Computer Science and Technology, University of Cambridge , Cambridge CB3 0FD, United Kingdom

2. Health Data Research UK , London NW1 2BE, United Kingdom

3. Division of Informatics, Imaging and Data Sciences, University of Manchester , Manchester M13 9PL, United Kingdom

4. Alan Turing Institute , London NW1 2DB, United Kingdom

5. Oncology Data Science, Oncology R&D AstraZeneca , Cambridge CB2 8PA, United Kingdom

Abstract

Abstract Motivation There exists a range of different quantification frameworks to estimate the synergistic effect of drug combinations. The diversity and disagreement in estimates make it challenging to determine which combinations from a large drug screening should be proceeded with. Furthermore, the lack of accurate uncertainty quantification for those estimates precludes the choice of optimal drug combinations based on the most favourable synergistic effect. Results In this work, we propose SynBa, a flexible Bayesian approach to estimate the uncertainty of the synergistic efficacy and potency of drug combinations, so that actionable decisions can be derived from the model outputs. The actionability is enabled by incorporating the Hill equation into SynBa, so that the parameters representing the potency and the efficacy can be preserved. Existing knowledge may be conveniently inserted due to the flexibility of the prior, as shown by the empirical Beta prior defined for the normalized maximal inhibition. Through experiments on large combination screenings and comparison against benchmark methods, we show that SynBa provides improved accuracy of dose–response predictions and better-calibrated uncertainty estimation for the parameters and the predictions. Availability and implementation The code for SynBa is available at https://github.com/HaotingZhang1/SynBa. The datasets are publicly available (DOI of DREAM: 10.7303/syn4231880; DOI of the NCI-ALMANAC subset: 10.5281/zenodo.4135059).

Funder

Health Data Research UK

The Alan Turing Institute Wellcome PhD Programme in Health Data Science

Wellcome Cambridge Trust Scholarship

Wellcome Trust

Publisher

Oxford University Press (OUP)

Subject

Computational Mathematics,Computational Theory and Mathematics,Computer Science Applications,Molecular Biology,Biochemistry,Statistics and Probability

Reference23 articles.

1. The toxicity of poisons applied jointly;Bliss;Ann Appl Biol,1939

2. Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives;Bulusu;Drug Discov Today,2016

3. The search for synergy: a critical review from a response surface perspective;Greco;Pharmacol Rev,1995

4. The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves;Hill;J. Physiol,1910

5. The national cancer institute ALMANAC: a comprehensive screening resource for the detection of anticancer drug pairs with enhanced therapeutic activity;Holbeck;Cancer Res,2017

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3